To investigate whether and how TME signaling is attributed to FGFR1 overactivation, we performed single-cell RNA-Seq (scRNA-Seq) to analyze the crosstalk between prostate cancer cells and other types of cells in the microenvironment. The gene discussed is FGFR1; the disease is prostate carcinoma.